Logo

American Heart Association

  36
  0


Final ID:

Canakinumab - can it find a role for CAD?

  • Ridker, Paul  ( BRIGHAM WOMENS HOSPITAL , Boston , Massachusetts , United States )
  • Author Disclosures:
    Paul Ridker: DO have relevant financial relationships ; Research Funding (PI or named investigator):Kowa, Novartis, Pfizer, NovoNordisk:Active (exists now) ; Advisor:Uppton, Bitteroot Bio, Angiowave, Peter Munk University of Toronto, Leducq Foundation:Active (exists now) ; Consultant:Novartis, Novo Nordisk, Agepha, Ardelyx, Arrowhead, AstraZeneca, CSK Behring, Civi Biopharm, GSK, Eil Lilly, New Amsterdam, CardioTherapeutics, Caristo, Tourmaline Bio:Active (exists now)
Meeting Info:

Scientific Sessions 2025

2025

New Orleans, Louisiana

Session Info:

Inflammation, Pollution, Microplastics and CAD

Saturday, 11/08/2025 , 01:30PM - 02:45PM

Cardiovascular Seminar

You have to be authorized to contact abstract author. Please, Login
Not Available